• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: DEPRESSION

New drug approvals in 2020

February 5, 2020  

Antidepressants – mixed scorecard in 2019

December 19, 2019  

Future look: Drug approvals pending for 2020

December 5, 2019  

FDA advisors recommend intranasal ketamine in depression

February 20, 2019  

Always online: problem or addiction?

February 13, 2019  

Comorbidity – a publishing phenomenon

February 14, 2018  

Vortioxetine: Improved work productivity in adults with major depression

December 13, 2017  

Adversity, hunger and early-life depression: 2 reports

March 22, 2017  

APA highlights: Treatment trials in psychiatry

June 22, 2016  

Weight gain common with some antidepressant combinations

June 1, 2016  
1
2
3
4

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Ultomiris (ravulizumab) now publicly reimbursed in gMG posted on April 7, 2026
  • Ofatumumab – new data on efficacy and safety posted on April 14, 2025
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions